Analyst Research

Report Title Price
Provider: Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Valneva SE Announces Sale of its Clinical Manufacturing Operations (CMO) in France to Biological E

Friday, 7 Jun 2013 02:01am EDT 

Valneva SE announced the signing of a binding term sheet to sell its Clinical Manufacturing Operations (CMO) in Nantes to Biological E, an Indian biopharmaceutical company. The financial terms of the deal were not disclosed. 

Company Quote

-0.07 -1.49%
7:30am EST